Supported by federal, foundation, and institutional funding.
Our research is made possible by grants and awards from the organizations below — spanning national genetics consortia, private foundations, and MGH’s own research infrastructure.
The organizations behind the work.
National Institutes of Health (NIH)
The NIH is the primary source of federal funding for the genetics consortia and cohort studies this team participates in, including MAGIC, TOPMed, and DIAMANTE.
American Diabetes Association (ADA)
ADA funding supports two active lines of work: the study of host genetics underlying diabetes and COVID-19 severity, and the characterization of beta-cell function and sulfonylurea response in people at the extremes of genetic risk.
See the COVID Study →
Boston Area Diabetes Endocrinology Research Center (BADERC)
Dr. Leong serves on BADERC’s Executive Committee as Associate Director, and directs its Pilot and Feasibility Program and the BADERC-Broad Collaborative Grant Program. BADERC’s Pilot and Feasibility Program helped fund the team’s work on genetics and A1C-glycemia mismatch.
See the CGM-A1c Genetics Study →
Doris Duke Foundation
A Doris Duke Foundation Clinical Scientist Development Award supports Dr. Leong’s work examining the association between HbA1c genetics and glycemia mismatches across ancestries.
See the CGM-A1c Genetics Study →
MGH Executive Committee on Research (ECOR)
ECOR fosters innovation at Massachusetts General Hospital by supporting early-stage and cross-disciplinary research — including infrastructure and pilot support that helps this team’s studies get off the ground before larger federal or foundation funding is secured.
What’s currently funded, and by whom.
Host genetics underlying diabetes and COVID-19 severity
Examining whether genetic risk for cardiometabolic disease shapes the severity of COVID-19 illness.
See the COVID Study →Beta-cell function and sulfonylurea response at the extremes of polygenic risk
Characterizing physiologic and pharmacologic responses in people with extreme genetic risk for type 2 diabetes.
See the TARGET Study →+ Doris Duke Foundation
Genetics and A1C-glycemia mismatch
Recall-by-genotype study examining how HbA1c-related genetic variants cause discordance between HbA1c and true average glycemia, across ancestries.
See the CGM-A1c Genetics Study →
